@misc{indiciaed08344c2d433,
  title = {Therapeutically advantageous secondary targets of abemaciclib identified by multi-omics profiling of CDK4/6 inhibitors},
  author = {Hafner, M. and Mills, C. E. and Subramanian, K. and Chen, C. and Chung, M. and Boswell, S. A. and Everley, R. A. and Walmsley, C. S. and Juric, D. and Sorger, P.},
  year = {2017},
  doi = {10.1101/211680},
  url = {https://www.biorxiv.org/content/10.1101/211680v1},
  note = {Source identifier: 10.1101/211680}
}